1. Home
  2. FIHL vs WGS Comparison

FIHL vs WGS Comparison

Compare FIHL & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fidelis Insurance Holdings Limited

FIHL

Fidelis Insurance Holdings Limited

HOLD

Current Price

$18.53

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$88.18

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIHL
WGS
Founded
2014
2017
Country
Bermuda
United States
Employees
N/A
1300
Industry
Retail: Computer Software & Peripheral Equipment
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
FIHL
WGS
Price
$18.53
$88.18
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$22.36
$140.71
AVG Volume (30 Days)
437.7K
710.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.34
$29.98
Revenue Next Year
$7.05
$24.85
P/E Ratio
N/A
$1,251.58
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$55.17
52 Week High
$20.50
$170.87

Technical Indicators

Market Signals
Indicator
FIHL
WGS
Relative Strength Index (RSI) 39.09 49.00
Support Level $18.56 $78.80
Resistance Level $19.05 $95.94
Average True Range (ATR) 0.53 5.76
MACD -0.13 1.35
Stochastic Oscillator 21.93 80.83

Price Performance

Historical Comparison
FIHL
WGS

About FIHL Fidelis Insurance Holdings Limited

Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: